Preimplantation genetic diagnosis liberalised in Germany before 2027?
One-OffHealth & MedicineCienciaRegulaciónEurope3mManifold MarketsSin KYCDatos de resolución verificadosCalibración aceptablePronóstico comunitario actualNo 90.9%
Pronosticadores
13
Tipo de pregunta
binary
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Datos de mercado
Actualizado hace 7 horas
Desactualizado3 jul 25, 16:03 UTC31 dic 26, 23:59 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Will there be any genetic modification which substantially reduces suffering in vertebrates by end of 2026?
Manifold MarketsBumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?
FutuurIs there a genetic contribution of at least 50% to the black/white IQ gap in 2023? [Resolves to the popular consensus in 2060]
Manifold MarketsBy 2030, will gene editing to cure serious genetic diseases be seen as generally uncontroversial?
Manifold MarketsWill 3 mg THC beverages be federally legal to sell?
KalshiHow much will ACA Marketplace enrollment decline in 2027?
KalshiReglas
Preimplantation genetic diagnosis (PGD) is currently permitted in Germany under specific conditions, primarily to prevent severe hereditary diseases.
- This market assesses whether PGD will become more broadly available in Germany by December 31, 2026.
- Resolution will be based on official announcements from the German Federal Ministry of Health or reputable news sources confirming expanded access to PGD services.
Mercados abiertos
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volumen total
- 15,6 M €
- Volumen 24h
- 18,3 mil €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volumen total
- 1,6 M €
- Volumen 24h
- 5,2 mil €
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 resultados más
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Volumen total
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volumen total
- 916 mil €
- Volumen 24h
- 1,5 mil €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 resultados más
- Volumen total
- 863,6 mil €
- Volumen 24h
- 1 mil €
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
Preguntas frecuentes
- ¿Cuáles son las probabilidades actuales de Preimplantation genetic diagnosis liberalised in Germany before 2027??
- Manifold Markets cotiza No al 91% a fecha de 8 de septiembre de 2026.
- ¿Cuándo se resuelve Preimplantation genetic diagnosis liberalised in Germany before 2027??
- Está previsto que Preimplantation genetic diagnosis liberalised in Germany before 2027? se resuelva el 31 de diciembre de 2026.
- ¿Cómo se liquida Preimplantation genetic diagnosis liberalised in Germany before 2027??
- Manifold Markets liquida este mercado del siguiente modo: Preimplantation genetic diagnosis (PGD) is currently permitted in Germany under specific conditions, primarily to prevent severe hereditary diseases.